| Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model M Kawamura, S Miyagawa, K Miki, A Saito, S Fukushima, T Higuchi, ... Circulation 126 (11_suppl_1), S29-S37, 2012 | 560 | 2012 |
| Enhanced survival of transplanted human induced pluripotent stem cell–derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a … M Kawamura, S Miyagawa, S Fukushima, A Saito, K Miki, E Ito, ... Circulation 128 (11_suppl_1), S87-S94, 2013 | 231 | 2013 |
| Efficient detection and purification of cell populations using synthetic microRNA switches K Miki, K Endo, S Takahashi, S Funakoshi, I Takei, S Katayama, T Toyoda, ... Cell stem cell 16 (6), 699-711, 2015 | 210 | 2015 |
| Enhanced engraftment, proliferation and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes S Funakoshi, K Miki, T Takaki, C Okubo, T Hatani, K Chonabayashi, ... Scientific reports 6 (1), 19111, 2016 | 207 | 2016 |
| Cardiomyocytes derived from MHC-homozygous induced pluripotent stem cells exhibit reduced allogeneic immunogenicity in MHC-matched non-human primates T Kawamura, S Miyagawa, S Fukushima, A Maeda, N Kashiyama, ... Stem cell reports 6 (3), 312-320, 2016 | 133 | 2016 |
| Bioengineered myocardium derived from induced pluripotent stem cells improves cardiac function and attenuates cardiac remodeling following chronic myocardial infarction in rats K Miki, H Uenaka, A Saito, S Miyagawa, T Sakaguchi, T Higuchi, ... Stem cells translational medicine 1 (5), 430-437, 2012 | 115 | 2012 |
| Enhanced therapeutic effects of human iPS cell derived-cardiomyocyte by combined cell-sheets with omental flap technique in porcine ischemic cardiomyopathy model M Kawamura, S Miyagawa, S Fukushima, A Saito, K Miki, S Funakoshi, ... Scientific reports 7 (1), 8824, 2017 | 108 | 2017 |
| MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells CJC Parr, S Katayama, K Miki, Y Kuang, Y Yoshida, A Morizane, ... Scientific reports 6 (1), 32532, 2016 | 89 | 2016 |
| In vivo differentiation of induced pluripotent stem cell-derived cardiomyocytes T Yu, S Miyagawa, K Miki, A Saito, S Fukushima, T Higuchi, M Kawamura, ... Circulation Journal 77 (5), 1297-1306, 2013 | 70 | 2013 |
| Efficient, selective removal of human pluripotent stem cells via ecto-alkaline phosphatase-mediated aggregation of synthetic peptides Y Kuang, K Miki, CJC Parr, K Hayashi, I Takei, J Li, M Iwasaki, ... Cell chemical biology 24 (6), 685-694. e4, 2017 | 66 | 2017 |
| ERRγ enhances cardiac maturation with T-tubule formation in human iPSC-derived cardiomyocytes K Miki, K Deguchi, M Nakanishi-Koakutsu, A Lucena-Cacace, S Kondo, ... Nature Communications 12 (1), 3596, 2021 | 41 | 2021 |
| Human iPS-derived pre-epicardial cells direct cardiomyocyte aggregation expansion and organization in vitro JJ Tan, JP Guyette, K Miki, L Xiao, G Kaur, T Wu, L Zhu, KJ Hansen, ... Nature communications 12 (1), 4997, 2021 | 30 | 2021 |
| Optical recording of action potentials in human induced pluripotent stem cell-derived cardiac single cells and monolayers generated from long QT syndrome type 1 patients T Takaki, A Inagaki, K Chonabayashi, K Inoue, K Miki, S Ohno, ... Stem cells international 2019, 2019 | 30 | 2019 |
| Monitoring and visualizing microRNA dynamics during live cell differentiation using microRNA-responsive non-viral reporter vectors H Nakanishi, K Miki, KR Komatsu, M Umeda, M Mochizuki, A Inagaki, ... Biomaterials 128, 121-135, 2017 | 23 | 2017 |
| Induction of human induced pluripotent stem cells to cardiomyocytes using embryoid bodies T Hatani, K Miki, Y Yoshida Experimental Models of Cardiovascular Diseases: Methods and Protocols, 79-92, 2018 | 20 | 2018 |
| Making steady progress on direct cardiac reprogramming toward clinical application K Miki, Y Yoshida, S Yamanaka Circulation research 113 (1), 13-15, 2013 | 16 | 2013 |
| Uncertainty quantification and robust predictive system analysis for high temperature kinetics of HCN/O2/Ar mixture SH Cheung, K Miki, E Prudencio, C Simmons Chemical Physics 475, 136-152, 2016 | 14 | 2016 |
| ERRγ agonist under mechanical stretching manifests hypertrophic cardiomyopathy phenotypes of engineered cardiac tissue through maturation Y Fujiwara, K Miki, K Deguchi, Y Naka, M Sasaki, A Sakoda, M Narita, ... Stem Cell Reports 18 (11), 2108-2122, 2023 | 3 | 2023 |
| A Method for Contraction Force Measurement of hiPSC-Derived Engineered Cardiac Tissues Y Fujiwara, K Deguchi, K Miki, T Nishimoto, Y Yoshida Pluripotent Stem-Cell Derived Cardiomyocytes, 171-180, 2021 | 3 | 2021 |
| Intratracheally injected human-induced pluripotent stem cell-derived pneumocytes and endothelial cells engraft in the distal lung and ameliorate emphysema in a rat model W Altalhi, T Wu, GR Wojtkiewicz, S Jeffs, K Miki, HC Ott The Journal of Thoracic and Cardiovascular Surgery 166 (1), e23-e37, 2023 | 1 | 2023 |
